Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma

This paper is a report of response rate (RR) and survival of 34 metastatic melanoma patients who received a dinitrophenyl (DNP)-modified autologous melanoma cell vaccine. In all, 27 patients started the vaccine as a primary treatment for metastatic melanoma and seven started it as an adjuvant, with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lotem, M, Shiloni, E, Pappo, I, Drize, O, Hamburger, T, Weitzen, R, Isacson, R, Kaduri, L, Merims, S, Frankenburg, S, Peretz, T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2004
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2410164/
https://ncbi.nlm.nih.gov/pubmed/14970852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601563
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados